FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer

被引：0
|
作者：
F Bertolini
N Malavasi
L Scarabelli
F Fiocchi
B Bagni
C Del Giovane
G Colucci
G E Gerunda
R Depenni
S Zironi
A Fontana
E Pettorelli
G Luppi
P F Conte
机构：
[1] Oncology,Haematology and Respiratory Diseases Department
[2] University Hospital of Modena,Nuclear Medicine Division
[3] Radiology Institute,Multiorgan Transplantation Division
[4] University Hospital of Modena,undefined
[5] University Hospital of Modena,undefined
[6] General Surgery,undefined
[7] Vignola Hospital,undefined
[8] Azienda USL Modena,undefined
[9] University Hospital of Modena,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
bevacizumab; liver metastases; colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1079 / 1084
页数：5
相关论文
共 50 条
  • [31] Optimal approach to potentially resectable liver metastases from colorectal cancer
    Falcone, Alfredo
    Fornaro, Lorenzo
    Loupakis, Fotios
    Masi, Gianluca
    Vasile, Enrico
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (10) : 1533 - 1539
  • [32] Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study
    Takao Takahashi
    Yoshihisa Shibata
    Yuichiro Tojima
    Kenji Tsuboi
    Eiji Sakamoto
    Katsuyuki Kunieda
    Hiroshi Matsuoka
    Kazuyoshi Suzumura
    Mikinori Sato
    Tatsushi Naganuma
    Junichi Sakamoto
    Satoshi Morita
    Ken Kondo
    International Journal of Clinical Oncology, 2013, 18 : 335 - 342
  • [33] Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases
    Pietrantonio, Filippo
    Cotsoglou, Christian
    Fuca, Giovanni
    Lo Vullo, Salvatore
    Nichetti, Federico
    Milione, Massimo
    Coppa, Jorgelina
    Vaiani, Marta
    Alessi, Alessandra
    Prisciandaro, Michele
    Busset, Michele Droz-Dit
    Morano, Federica
    Corallo, Salvatore
    Lazzati, Silvia
    Antista, Maria
    Mennitto, Alessia
    Randon, Giovanni
    Raimondi, Alessandra
    Belfiore, Antonino
    Padovano, Barbara
    Perrone, Federica
    Mariani, Luigi
    Di Bartolomeo, Maria
    de Braud, Filippo
    Mazzaferro, Vincenzo
    CLINICAL COLORECTAL CANCER, 2019, 18 (01) : 34 - +
  • [34] TRAIL Receptor Agonist Conatumumab With Modified FOLFOX6 Plus Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer
    Fuchs, Charles S.
    Fakih, Marwan
    Schwartzberg, Lee
    Cohn, Allen L.
    Yee, Lorrin
    Dreisbach, Luke
    Kozloff, Mark F.
    Hei, Yong-jiang
    Galimi, Francesco
    Pan, Yang
    Haddad, Vincent
    Hsu, Cheng-Pang
    Sabin, Antony
    Saltz, Leonard
    CANCER, 2013, 119 (24) : 4290 - 4298
  • [35] Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study
    Takahashi, Takao
    Shibata, Yoshihisa
    Tojima, Yuichiro
    Tsuboi, Kenji
    Sakamoto, Eiji
    Kunieda, Katsuyuki
    Matsuoka, Hiroshi
    Suzumura, Kazuyoshi
    Sato, Mikinori
    Naganuma, Tatsushi
    Sakamoto, Junichi
    Morita, Satoshi
    Kondo, Ken
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (02) : 335 - 342
  • [36] Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial
    Janja Ocvirk
    Thomas Brodowicz
    Fritz Wrba
    Tudor E Ciuleanu
    Galina Kurteva
    Semir Beslija
    Ivan Koza
    Zsuzsanna Pápai
    Diethelm Messinger
    Ugur Yilmaz
    Zsolt Faluhelyi
    Suayib Yalcin
    Demetris Papamichael
    Miklós Wenczl
    Zrinka Mrsic-Krmpotic
    Einat Shacham-Shmueli
    Damir Vrbanec
    Regina Esser
    Werner Scheithauer
    Christoph C Zie-linski
    World Journal of Gastroenterology, 2010, 16 (25) : 3133 - 3143
  • [37] XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis
    Maniadakis, Nikos
    Fragoulakis, Vasilios
    Pectasides, Dimitrios
    Fountzilas, George
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) : 797 - 805
  • [38] Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial
    Ocvirk, Janja
    Brodowicz, Thomas
    Wrba, Fritz
    Ciuleanu, Tudor E.
    Kurteva, Galina
    Beslija, Semir
    Koza, Ivan
    Zsuzsanna Papai
    Messinger, Diethelm
    Yilmaz, Ugur
    Zsolt Faluhelyi
    Yalcin, Suayib
    Papamichael, Demetris
    Miklos Wenczl
    Mrsic-Krmpotic, Zrinka
    Shacham-Shmueli, Einat
    Vrbanec, Damir
    Esser, Regina
    Scheithauer, Werner
    Zielinski, Christoph C.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (25) : 3133 - 3143
  • [39] An Update On Liver Transplantation for Non-Resectable Colorectal Liver Metastases
    Hagness, M.
    Solheim, J.
    Line, P.
    Dueland, S.
    Foss, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 701 - 702
  • [40] An Update on Liver Transplantation for Non-resectable Colorectal Liver Metastases
    Hagness, Morten
    Solheim, Jon M.
    Line, Pal-Dag
    Dueland, Svein
    Foss, Aksel
    LIVER TRANSPLANTATION, 2014, 20 : S258 - S258
12345